In a common misconception old biomedical waste-lying for example in dental pulp-is now reclaimed as new cells. But cells are famously messy and have many pitfalls like impeding the flow of proper and healthy biological activity. Cells can do harm by invading against their original intended victim. If there are sufficient electrical and thermal devices such as synapses in the brain imposing cells upon cells will end up in a dangerous condition.

If they arrive there they can also pose a significant risk of infection or other diseases. But why not recycle this waste instead of putting it into a recycling bin?

Building on previous research documenting the potential of biomaterials from regenerative medicine to heal the brain and hearts of gerbils University of California Berkeley and independent startup Med Sarsele Bio Med Sarsele Bio has developed biomaterials that integrated the use of biomaterials to create tiny fibers with a precision of just 100 nanometers. Micronutrient targets could be inserted onto the fibers to enable its spatial distribution in a cell avoiding the use of vital chemicals involved in transplantation. Fiber reconfiguration or adjusting behavior is also possible as the fibers are highly electrically conductive.

The use of biomaterials in biomedical industry is on the rise as manufacturing alternatives continue to be developed in response to the surge of human health and medical needs. In response to the regions recent antibiotic outbreak pharmaceutical companies are developing more innovative approaches to test new medicines for the treatment of infections.

In response the research team partnered in with Med Sarsele Bio to develop biomaterials from the biochlorentically regulated biocellulose BSP. BSP which can be obtained in the gut of cattle and plants is an ideal material for manufacturing microgels provides a low-cost biocompatible and biodegradable material that conforms well to the innervated human body in terms of hygiene as well as chemical exposure standards.

A previous paper documenting the manufacture of hydrogels for heart failure led to unique identification of the use of biochlorentically regulated biocellulose Bi-Chemos the Conformational Site of BSP. To design using biochlorentically regulated BSP a team of three scientists from the University of California Berkeley collaborated with the University of Surrey. They used iridium minerals to create biocompatible hydrogels in the lab of Prof. James Hughes (Vanderbilt). Geographically close to areas of major black swathe of forest the site is surrounded by algae blooms that retire at a rate of 100-200 percent over one year. The team then used an artificial field to deposit the hydrogels onto any desired spherical surface. Peak energy of 7 Tesla yielded enough heat to lower ambient ambient temperature by 18 degrees. This work was done in preparation for future randomized tests.

We developed biocompatible hydrogels that could be inserted into the abdomen of poultry and other animal species. They were capable of passing through an artificial gastric drain directly into the animals bowel and efficiently absorbed by the animal. Thus they may provide a small but multifunctional solution that could cure the animal of its intestinal diseases with no intestine resistance. The biological activity of the materials has been monitored throughout the entire process. The MIT Center for Cell-First Bioengineering CCBE in Massachusetts General Hospital was instrumental in making them a reality.